AI-generated summary
This review discusses how phototherapy is used in patients with skin of color, noting that treatment choice, dosing and duration need special consideration. The authors report that some diseases seen more often in these patients may respond better to newer options such as long pulsed Nd:YAG laser or UVA1. The abstract does not describe a specific number of studies or patients.
- Who or what was studied
- Patients with skin of color receiving phototherapy for inflammatory and pigmentary skin diseases
- Limits stated in the abstract
- The abstract does not state the review methods, number of included studies, or certainty of the reported outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on scmsjournal.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Phototherapy, Ultraviolet, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.